We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » SANOFI-SYNTHELABO, AVENTIS MERGER PART OF PRICE-DRIVEN TREND
SANOFI-SYNTHELABO, AVENTIS MERGER PART OF PRICE-DRIVEN TREND
April 26, 2004
French drugmaker Aventis’ acceptance of Sanofi-Synthelabo’s improved stock-and-cash bid is part of a larger market trend being driven by increasing concern over pricing issues, according to industry analysts.